OBX
Obsidian Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.75
+1.43%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$1.63
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- -$2.05
- EPS estimate
- -$2.05
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $43
- PT range
- $42 – $43
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 28, 2026 | -$2.05 | -$2.05 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026